VLDL compositional changes and plasma levels of triglycerides and high density lipoprotein

Clinica Chimica Acta

Volumn 269, Issue 2, 1998, Pages 107-124

  Brites, Fernando D ^a   Bonavita, Carla D ^a   Cloës, Marcelo ^b   Yael, Mario J ^a   Fruchart, Jean Charles ^b   Castro, Graciela R ^b   Wikinski, Regina W ^a  

^a Dept Clin Biochem Sch Pharm B   (Argentina)

^b INSTITUT PASTEUR DE LILLE   (France)

Author keywords

Apolipoproteins C III and E; CETP; HDL; Hypertriglyceridemia; Hypoalphalipoproteinemia; VLDL

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; APOLIPOPROTEIN C3; APOLIPOPROTEIN E; CHOLESTEROL; CHOLESTEROL ESTER; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; HYPERTRIGLYCERIDEMIA; HYPOLIPOPROTEINEMIA; LIPID COMPOSITION; LIPID TRANSPORT; MALE; PRIORITY JOURNAL;

ADULT; APOLIPOPROTEIN C-III; APOLIPOPROTEINS C; APOLIPOPROTEINS E; HUMANS; LIPOPROTEINS, HDL; LIPOPROTEINS, VLDL; MALE; MIDDLE AGED; TRIGLYCERIDES;

EID: 0032579151     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(97)00193-9     Document Type: Article

References (43)

1. Hulley SB, Rosenman RH, Bawol RD, Brand RJ Epidemiology as a guide to clinical decisions. The association between triglyceride and coronary heart disease. N Engl J Med. 302:1980;1383-1389.
2. Krauss RM Relationship of intermediate and low-density lipoprotein subspecies to risk of coronary artery disease. Am Heart J. 113:1987;578-582.
3. Austin MA Plasma triglyceride as a risk factor for coronary heart disease. The epidemiologic evidence and beyond. Am J Epidemiol. 129:1989;249-259.
4. Eisenberg S Lipoprotein abnormalities in hypertriglyceridemia: significance in atherosclerosis. Am Heart J. 113:1987;555-561.
5. Wikinski RLW, Schreier LE, Rosental SB New method for isolating and quantifying intermediate and β-very-low-density lipoprotein cholesterol. Clin Chem. 37:1991;1913-1916.
6. Alaupovic P The role of apolipoproteins in lipid transport processes. Ric Clin Lab. 12:1982;3-21.
7. Cohn JS, Tremblay M, Amiot Met al. Plasma concentration of apolipoprotein E in intermediate-sized remnant-like lipoproteins in normolipidemic and hyperlipidemic subjects. Arterioscler Thromb Vasc Biol. 16:1996;149-159.
8. The International Committee for the Evaluation of Hypertriglyceridemia as a Vascular Risk Factor. The hypertriglyceridemias: risk and management. Am J Cardiol 1991;68:1A-42A.
9. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment, Panel II). Summary of Second Report of the National Cholesterol Education Program (NCEP). J Am Med Assoc 1993;269:3015-23.
10. Coniglio RI La hipertrigliceridemia como factor de riesgo para la aterosclerosis coronaria. Acta Bioq Clin Latinoam. 29:1995;129-137.
11. Glomset JA The plasma lecithin:cholesterol acyltransferase reaction. J Lipid Res. 9:1968;155-167.
12. Blum CB Dynamics of apolipoprotein E metabolism in humans. J Lipid Res. 23:1982;1308-1316.
13. Eisenberg S, Olivecrona T Very low density lipoprotein. Fate of phospholipids, cholesterol, and apolipoprotein C during lipolysis in vitro. J Lipid Res. 20:1979;614-623.
14. Saku K, Gartside PS, Hynd BA, Mendoza SG, Kashyap ML Apolipoprotein AI and AII metabolism in patients with primary high-density lipoprotein deficiency associated with familial hypertriglyceridemia. Metabolism. 34:1985;754-764.
15. Le NA, Ginsberg HN Heterogeneity of apolipoprotein A-I turnover in subjects with reduced concentrations of plasma high density lipoprotein cholesterol. Metabolism. 37:1988;614-617.
16. Rao SN, Magill PJ, Miller NE, Lewis B Plasma high-density lipoprotein metabolism in subjects with primary hypertriglyceridaemia: altered metabolism of apoproteins A I and A II. Clin Sci. 59:1980;359-367.
17. Lagrost L Regulation of cholesteryl ester transfer protein (CETP) activity: review of in vitro and in vivo studies. Biochim Biophys Acta. 1215:1994;209-236.
18. Lamarche B, Després JP, Pouliot MCet al. Metabolic heterogeneity associated with high plasma triglyceride or low HDL cholesterol levels in men. Arterioscler Thromb. 13:1993;33-40.
19. Gianturco SH, Bradley WA Triglyceride-rich lipoproteins and their role in atherogenesis. Curr Opin Lipidol. 2:1991;324-328.
20. Eisenberg S, Gavish D, Oschry Y, Fainaru M, Deckelbaum RJ Abnormalities in very low, low and high density lipoproteins in hypertriglyceridemia. Reversal toward normal with bezafibrate treatment. J Clin Invest. 74:1984;470-482.
21. Bradley WA, Gianturco SH Triglyceride-rich lipoproteins and atherosclerosis: pathophysiological considerations. J Intern Med. 236:1994;33-39.
22. Gianturco SH, Bradley WA, Gotto AM, Morrisett JD, Peavy DL Hypertriglyceridemic very low density lipoproteins induce triglyceride synthesis and accumulation in mouse peritoneal macrophages. J Clin Invest. 70:1982;168-178.
23. Schumaker VN, Puppione DL Sequential flotation ultracentrifugation. Methods Enzymol. 128:1986;155-170.
24. Noble RP Electrophoretic separation of plasma lipoproteins in agarose gel. J Lipid Res. 9:1968;693-700.
25. 2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol. Clin Chem. 28:1982;1379-1388.
26. Assmann G, Jabs HU, Kohnert U, Nolte W, Schriewer H LDL (low-density-lipoprotein) cholesterol determination in blood serum following precipitation of LDL with poly(vinyl sulphate). Clin Chim Acta. 140:1984;77-83.
27. Bartlett GR Phosphorus assay in column chromatography. J Biol Chem. 234:1959;466-468.
28. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ Protein measurement with the folin phenol reagent. J Biol Chem. 193:1951;265-275.
29. Shen BW, Scanu AM, Kézdy FJ Structure of human serum lipoproteins inferred from compositional analysis. Proc Natl Acad Sci USA. 74:1977;837-841.
30. Lagrost L, Barter PJ Effects of various non-esterified fatty acids on the transfer of cholesteryl esters from HDL to LDL induced by the cholesteryl ester transfer protein. Biochim Biophys Acta. 1085:1991;209-216.
31. Tollefson JH, Albers JJ Isolation, characterization, and assay of plasma lipid transfer proteins. Methods Enzymol. 129:1986;797-816.
32. Lagrost L, Gandjini H, Athias A, Guyard-Dangremont V, Lallemant C, Gambert P Influence of plasma cholesteryl ester transfer activity on the LDL and HDL distribution profiles in normolipidemic subjects. Arterioscler Thromb. 13:1993;815-825.
33. Donahue RP, Abbott RD, Bloom E, Reed D, Yano K Central obesity and coronary heart disease in men. Lancet. 8537:1987;821-824.
34. Reaven GM, Mondon CE, Ida Chen YD, Breslow JL Hypertriglyceridemic mice transgenic for the human apolipoprotein C-III gene are neither insulin resistant nor hyperinsulinemic. J Lipid Res. 35:1994;820-824.
35. Austin MA, King MC, Vranizan KM, Krauss RM Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk. Circulation. 82:1990;495-506.
36. Assmann G, Schulte H, von Eckardstein A, Huang Y High-density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transport. Atherosclerosis. 124:1996;S11-S20.
37. Manzato E, Zambon S, Zambon A, Cortella A, Sartore G, Crepaldi G Levels and physicochemical properties of lipoprotein subclasses in moderate hypertriglyceridemia. Clin Chim Acta. 219:1993;57-65.
38. Van Barlingen HHJJ, Kock LAW, De Man FHAF, Erkelens DW, De Bruin TWA In vitro lipolysis of human VLDL: effect of different VLDL compositions in normolipidemia, familial combined hyperlipidemia and familial hypertriglyceridemia. Atherosclerosis. 121:1996;75-84.
39. Aalto-Setälä K, Fisher EA, Chen Xet al. Mechanism of hypertriglyceridemia in human apolipoprotein (apo) CIII transgenic mice. J Clin Invest. 90:1992;1889-1900.
40. Maeda N, Li H, Lee D, Oliver P, Quarfordt SH, Osada J Targeted disruption of the apolipoprotein C-III gene in mice results in hypotriglyceridemia and protection from postprandial hypertriglyceridemia. J Biol Chem. 269:1994;23610-23616.
41. Mahley RW Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science. 240:1988;622-630.
42. Chivot L, Mainard F, Bigot Eet al. Logistic discriminant analysis of lipids and apolipoproteins in a population of coronary bypass patients and the significance of apolipoproteins C-III and E. Atherosclerosis. 82:1990;205-211.
43. Luc G, Fievet C, Arveiler Det al. Apolipoproteins C-III and E in apoB- and non-apoB-containing lipoproteins in two populations at contrasting risk for myocardial infarction: the ECTIM study. J Lipid Res. 37:1996;508-517.